B. Riley Comments on Aspen Aerogels FY2024 Earnings

Aspen Aerogels, Inc. (NYSE:ASPN) – Equities research analysts at B. Riley issued their FY2024 EPS estimates for shares of Aspen Aerogels in a note issued to investors on Monday, January 6th. B. Riley analyst R. Pfingst forecasts that the construction company will post earnings of $0.16 per share for the year. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.11 per share. B. Riley also issued estimates for Aspen Aerogels’ Q4 2024 earnings at $0.14 EPS, Q1 2025 earnings at $0.09 EPS, Q2 2025 earnings at $0.12 EPS, Q3 2025 earnings at $0.16 EPS, Q4 2025 earnings at $0.18 EPS, FY2025 earnings at $0.54 EPS, FY2026 earnings at $0.87 EPS and FY2027 earnings at $1.33 EPS.

Other equities research analysts have also issued reports about the stock. Piper Sandler decreased their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. HC Wainwright reaffirmed a “buy” rating and set a $30.00 price target on shares of Aspen Aerogels in a report on Wednesday, October 16th. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a report on Wednesday, November 13th. Barclays decreased their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday, November 12th. Finally, Roth Mkm decreased their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $30.00.

Aspen Aerogels Trading Down 4.9 %

Shares of Aspen Aerogels stock opened at $12.52 on Thursday. The firm has a market capitalization of $1.03 billion, a PE ratio of 1,253.25 and a beta of 2.14. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The firm’s 50 day moving average is $13.94 and its 200 day moving average is $20.64. Aspen Aerogels has a 1 year low of $10.75 and a 1 year high of $33.15.

Institutional Investors Weigh In On Aspen Aerogels

A number of institutional investors have recently modified their holdings of the company. Franklin Resources Inc. lifted its position in shares of Aspen Aerogels by 5.3% during the 3rd quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock valued at $815,000 after acquiring an additional 1,483 shares during the period. nVerses Capital LLC lifted its position in shares of Aspen Aerogels by 45.0% during the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock valued at $161,000 after acquiring an additional 1,800 shares during the period. Point72 Hong Kong Ltd acquired a new position in shares of Aspen Aerogels during the 2nd quarter valued at $84,000. Quent Capital LLC acquired a new position in shares of Aspen Aerogels during the 3rd quarter valued at $118,000. Finally, Point72 DIFC Ltd acquired a new position in shares of Aspen Aerogels during the 2nd quarter valued at $121,000. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.